Trial intelligence / Profile preview

PRIMM: Immediate Preoperative Chemotherapy in Colorectal Cancer

NCT01715363Phase 2Terminated

Sponsor
Gustave Roussy
Start
Jul 2012
Primary completion
Jun 2014
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in colorectal cancer (CRC), sponsored by Gustave Roussy. Started Jul 2012; status: terminated.

02

Drugs

oxaliplatinfluorouracilfolinic acid
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT01715363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01715363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call